Pemphigus Pain: A Review on Management

@article{Rashid2008PemphigusPA,
  title={Pemphigus Pain: A Review on Management},
  author={Rashid M. Rashid and Kenneth D. Candido},
  journal={The Clinical Journal of Pain},
  year={2008},
  volume={24},
  pages={734-735}
}
Pemphigus vulgaris is an autoimmune disease that commonly presents with painful persistent erosions and ulcers. ObjectiveThe current literature has focused on managing and maintaining remittance of this life-threatening disease. However, remission is not instantaneous and chronic pain is common. In this manuscript, we review the current peer reviewed works that elaborate specifically on pain management in pemphigus patients. MethodsA medline search was preformed and included any case report… 
Pain Management in Patients with Severe Pemphigus Vulgaris.
TLDR
This was a retrospective cohort study conducted in the Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán over the period 2013-2020 that described the pain management and clinical course of patients with severe Pemphigus Vulgaris admitted to a third-level Intensive Care Unit.
The role of sleep in pemphigus: a review of mechanisms and perspectives
TLDR
This review will explore the evidence supporting the likely bidirectional relationship between pemphigus and sleep quality and its possible mechanisms involved and open a research avenue for future studies focusing on the efficacy of the sleep disorders treatment in patients with pemPHigus.
Relieving Pain in Oral Lesions of Pemphigus Vulgaris Using the Non-ablative, Non-thermal, CO2 Laser Therapy (NTCLT): Preliminary Results of a Novel Approach.
TLDR
It is proposed that single session of NTCLT could immediately and significantly relieve pain in oral lesions of PV, without any visible thermal complications.
Presentación de un caso de Pénfigo Vulgar A case report of Pemphigus Vulgaris
TLDR
A case of atypical hyperpigmented pemphigus appearance is shown and the review of issue, especially on treatment is reviewed.
Itch-related quality of life impact across 3 autoimmune blistering diseases: a retrospective cohort study
TLDR
Disease severity was significantly associated with itch-related QoL in BP and pemphigus, as was use of biological/targeted therapies in BP alone, and further studies are needed to elucidate the mechanisms for itch in AIBD.
Presentación de un caso de Pénfigo Vulgar
TLDR
A case of atypical hyperpigmented pemphigus appearance is shown and the review of issue, especially on treatment is reviewed.
Non-Thermal, Non-Ablative CO2 Laser Therapy (NACLT): A New Approach to Relieve Pain in Some Painful Oral Diseases
TLDR
The results of powermetry and thermometry demonstrated the low power nature of NACLT, however there are some differences between analgesic effects of NacLT and the other classical low power lasers which will be discussed in the next sections.

References

SHOWING 1-10 OF 13 REFERENCES
Differences and similarities among expert opinions on the diagnosis and treatment of pemphigus vulgaris.
TLDR
Wide variation exists in diagnostic techniques and treatment of PV, even among the world's experts, and there is clearly a need for consensus standards with regard to patient stratification and randomized controlled trials.
Use of biosynthetic dressings in paraneoplastic pemphigus
A 77‐year‐old woman with paraneoplastic pemphigus and non‐Hodgkin's lymphoma was treated with supportive therapy and oral prednisone. Biobrane®, a biosynthetic dressing, was later applied to the
Beneficial effects of topical tacrolimus on recalcitrant erosions of pemphigus vulgaris
We report a case of pemphigus vulgaris in which a recalcitrant area of erosion on the cheek cleared only when topical tacrolimus was used in addition to a regime of systemic therapy consisting of
Painful pemphigus vulgaris.
TLDR
Fiberoptic bronchoscopy showed typical OFTP, with a thick, tubular, milky, rubber-like opaque pseudomembrane molding covering 2–3 cm of the tracheal wall at the level of the endotracheal cuff, and OFTP’s pathological features suggest this lesion as an early stage oftracheal ischemic damage related to cuff-induced injury.
Pemphigus: an epidemiological study of patients treated in Finnish hospitals between 1969 and 1978.
TLDR
Between 1969 and 1978, 44 pemphigus (p.) patients were treated in Finnish hospitals, giving an annual incidence of 0.76 cases per million inhabitants and the mean annual number of hospitalization days was 16.4 days.
Pemphigus vulgaris: incidence in Jews of different ethnic groups, according to age, sex, and initial lesion.
TLDR
The oral cavity was the sole initial site in 56% of the cases, while 88 per cent of the patients have shown primary lesions in the oral cavity alone or combined with other sites.
Randomized controlled trial of adjuvant oral dexamethasone pulse therapy in pemphigus vulgaris: PEMPULS trial.
TLDR
In patients with new pemphigus vulgaris disease activity, there was no benefit of oral DP therapy given in addition to conventional treatment and the study found no statistically significant difference of an adjuvant effect of DP on remission of pem PHV.
Healing effect of Pilocarpine gel 4% on skin lesions of pemphigus vulgaris
TLDR
Based on a new theory on the pathophysiology of PV, cholinomimetics can block the process of blister formation and could lead to a new treatment strategy for PV.
Double-blind clinical trial of 0.05% clobetasol proprionate ointment in orabase and 0.05% fluocinonide ointment in orabase in the treatment of patients with oral vesiculoerosive diseases
TLDR
Clobetasol propionate was better than fluocinonide as measured by more rapid control of pain (within 7 days) and normal carriers should be identified and treatment with antifungal therapy instituted before the patient begins using topical steroids.
Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions: a series of cases.
TLDR
The observed effect of topical AZA suggests that it can be used for management of oral immune-mediated inflammatory conditions, and for patients who are provided with systemic immunosuppressives it can allow control of oral findings with lower systemic dosing.
...
1
2
...